Souhaitez-vous accéder aux communiqués récents ?

How chronic disease prevalence, infectious disease testing, AI investment, personalized medicine and regulatory change are shaping the diagnostics industry

How AI is moving from trial programs into enterprise systems, supporting real-time decisions, operational efficiency and competitive transformation.

According to BCC Research, AI is becoming a key driver of scalability, quality and circularity in plastics recycling at the global level.

AI-driven soil nutrient management is helping farmers save time, improve nutrient-use efficiency, and move beyond conventional application methods.

The analysis explores how intelligent packaging formats are reshaping pharmaceutical operations from early-stage product design to final distribution.

According to BCC Research, AI is transforming the cannabis value chain from cultivation and manufacturing to distribution, retail, and medical use.

Report examines corporate investment, private funding, mergers and acquisitions, venture capital, government grants, and regional AI investment patterns.

Explores AI-native architectures, generative AI, automation, robotics, data infrastructure, and intelligent decision-making as key forces reshaping markets

Emerging drugs market is expected to rise from $383.9 billion in 2024 to $558.0 billion by 2030, driven by faster regulations and increased R&D spending.

How sustainability, regulatory change, digital integration, and water quality concerns are reshaping the global membrane and filtration industry.